VK2735
Phase 3Recruiting 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Weight Loss
Conditions
Weight Loss
Trial Timeline
Jun 23, 2025 → Aug 1, 2027
NCT ID
NCT07104383About VK2735
VK2735 is a phase 3 stage product being developed by Viking Therapeutics for Weight Loss. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07104383. Target conditions include Weight Loss.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07104383 | Phase 3 | Recruiting |
| NCT07104500 | Phase 3 | Active |
Competing Products
20 competing products in Weight Loss